Global Trust Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Global Trust Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$548.35 - $738.84 $178,213 - $240,123	-325 Closed	0 $0
Q1 2022 Apr 12, 2022	BUY	$595.12 - $698.43 $193,414 - $226,989	325 New	325 $227,000
Q2 2020 Jul 08, 2020	SELL	$493.32 - $643.92 $345,324 - $450,744	-700 Closed	0 $0
Q1 2020 Apr 06, 2020	BUY	$336.18 - $494.43 $235,326 - $346,101	700 New	700 $331,000
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $1,370 - $1,882	-5 Closed	0 $0
Q3 2018 Oct 16, 2018	BUY	$351.14 - $408.51 $1,755 - $2,042	5 New	5 $2,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Global Trust Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Trust Asset Management, LLC with notifications on news.